Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment
Clinical trial NCT02341781 · COMPLETED
Trial details
- NCT number
- NCT02341781
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.